Factors affecting excitatory amino acid release following severe human head injury

Journal of Neurosurgery

Volumn 89, Issue 4, 1998, Pages 507-518

  Bullock, Ross ^a   Zauner, Alois ^a   Woodward, John J ^a   Myseros, John ^a   Choi, Sung C ^a   Ward, John D ^a   Marmarou, Anthony ^a   Young, Harold F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamate; Glutamate antagonist; Intracranial pressure; Microdialysis; Outcome; Severe head injury

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID;

AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN CONTUSION; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD INJURY; HUMAN; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MICRODIALYSIS; NERVE CELL LESION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031706636     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.4.0507     Document Type: Article

References (58)

1. Adams JH, Graham DI, Gennarelli TA: Head injury in man and experimental animals: neuropathology. Acta Neurochir (Suppl 32): 15-30, 1983
2. Becker DP, Katayama Y, Tamura T, et al: Excitotoxic ion fluxes and neuronal dysfunction following traumatic brain injury. J Cereb Blood Flow Metab 9 (Suppl 1):S302, 1989 (Abstract)
3. Benveniste H, Drejer J, Schousboe A, et al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374, 1984
4. Bouma GJ, Muizelaar JP, Stringer WA, et al: Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg 77:360-368, 1992
5. Bullock R: Opportunities for neuroprotective drugs in clinical management of head injury. J Emerg Med 11 (Suppl 1): 23-30, 1993
6. Bullock R, Butcher SP, Chen MH, et al: Correlation of extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg 74: 794-801, 1991
7. Bullock R, Fujisawa H: The role of glutamate antagonists for the treatment of CNS injury. J Neurotrauma 9 (Suppl 2): 5443-5462, 1992
8. Bullock R, Inglis FM, Kuroda Y, et al: Transient hippocampal hypermetabolism associated with glutamate release after acute subdural haematoma in the rat: a potentially neurotoxic mechanism. J Cereb Blood Flow Metab 11 (Suppl 2):S109, 1991 (Abstract)
9. Bullock R, Zauner A, Tsuji O, et al: Excitatory amino acid release after severe human head trauma: effect of intracranial pressure and cerebral perfusion pressure changes, in Nagai H, Kamiya K, Ishii S (eds): Intracranial Pressure IX. Tokyo: Springer-Verlag, 1994, pp 264-267
10. Bullock R, Zauner A, Tsuji O, et al: Patterns of excitatory amino acid release and ionic flux after severe head trauma, in Tsubokawa T, Marmarou A, Robertson C, et al (eds): Neurochemical Monitoring in the Intensive Care Unit. Tokyo: Springer-Verlag, 1995, pp 64-67
11. Butcher SP, Bullock R, Graham DL, et al: Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 21: 1727-1733, 1990
12. Chen MH, Bullock R, Graham DI, et al: Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. J Neurosurg 74: 944-950, 1991
13. Choi DW, Maulucci-Gedde M, Kriegstein AR: Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357-368, 1987
14. Choi SC, Chinchilli VM: Analysis of within- and across-subject correlations, in Bozdogan H, Gupta AK (eds): Multivariate Statistical Modeling and Data Analysis. Dordrecht: Reidel, 1989, pp 77-94
15. During MJ, Spencer DD: Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607-1610, 1993
16. Erb DE, Povlishock JT: Axonal damage in severe traumatic brain injury: an experimental study in the cat. Acta Neuropathol 76:347-358, 1988
17. Faden AI, Demediuk P, Panter SS, et al: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800, 1989
18. Gentleman D, Jennett B: Hazards of inter-hospital transfer of comatose head injured patients. Lancet 2:853-855, 1981
19. Graham DI, Lawrence AE, Adams JH, et al: Brain damage in fatal non-missile head injury without high intracranial pressure. J Clin Pathol 41:34-37, 1988
20. Hayes RL, Jenkins LW, Lyeth BG, et al: Pretreatment with phencyclidine, an N-methyl-D-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J Neurotrauma 5:259-274, 1988
21. Heiss WD, Hayakawa T, Waltz AG: Cortical neuronal function during ischemia. Effects of occlusion of one middle cerebral artery on single-unit activity in cats. Arch Neurol 33:813-820, 1976
22. Hillered L, Hallström A, Segersvärd S. et al: Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab 9:607-616, 1989
23. Hillered L, Persson L, Carlson H, et al: Studies on excitatory amino acid receptor-linked brain disorders in rat and man using in vivo microdialysis. Clin Neuropharmacol 15 (Suppl 1, Part A):695A-696A, 1992
24. Inglis F, Kuroda Y, Bullock R: Glucose hypermetabolism after acute subdural hematoma is ameliorated by a competitive NMDA antagonist. J Neurotrauma 9:75-84, 1992
25. Jenkins LW, Lyeth BG, Lewelt W, et al: Combined pretrauma scopolamine and phencyclidine attenuates posttraumatic increased sensitivity to delayed secondary ischemia. J Neurotrauma 5:275-287, 1988
26. Jenkins LW, Moszynski K, Lyeth BG, et al: Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res 477: 211-224, 1989
27. Jones TH, Morawetz RB, Crowell RM, et al: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54: 773-782, 1981
28. Katayama Y, Becker DP, Tamura T, et al: Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg 73: 889-900, 1990
29. Kawamata T, Katayama Y, Hovda D, et al: Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab 12:12-24, 1992
30. Kirino T, Tamura A, Sano K: Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 64:139-147, 1984
31. Kotapka MJ, Graham DI, Adams JH, et al: Hippocampal pathology in fatal non-missile human head injury. Acta Neuropathol 83:530-534, 1992
32. Kuroda Y, Fujisawa H, Strebel S, et al: Effect of neuroprotective N-methyl-D-aspartate antagonists on increased intracranial pressure: studies in the rat acute subdural hematoma model. Neurosurgery 35:106-112, 1994
33. Lindroth P, Mopper K: High performance liquid chromatographic determination of sub-picomole amounts of amino acids by precolumn fluorescence derivatization with o-pthaldialdehyde. Anal Chem 51:1667-1674, 1979
34. Lyeth BG, Jenkins LW, Hamm RJ, et al: Pretreatment with MK-801 reduces behavioral deficits following traumatic brain injury in rats. Soc Neurosci 15:1113, 1989 (Abstract)
35. McIntosh TK, Vink R, Soares H, et al: Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J Neurochem 55: 1170-1179, 1990
36. McIntosh TK, Vink R, Soares H, et al: Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J Neurotrauma 6:247-259, 1989
37. Meldrum B: Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metabol Rev 2:27-57, 1990
38. Meyer JS, Hayman LA, Yamamoto M, et al: Local cerebral blood flow measured by CT after stable xenon inhalation. AJR 135:239-251, 1980
39. Muizelaar JP, Schröder ML: Overview of monitoring of cerebral blood flow and metabolism after severe head injury. Can J Neurol Sci 21 (Suppl): 1-6, 1994
40. Nehls DG, Park CK, MacCormack AG, et al: The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilization. Brain Res 511:271-279, 1990
41. Nicholls D, Attwell D: The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11:462-468, 1990
42. 2+ levels following cortical compression contusion trauma in rats. J Cereb Blood Flow Metab 13: 183-192, 1993
43. Nilsson P, Hillered L, Pontén U, et al: Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J Cereb Blood Flow Metab 10:631-637, 1990
44. Persson L, Hillered L: Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg 76:72-80, 1992
45. Ronne-Engström E, Hillered L, Flink R, et al: Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 12:873-876, 1992
46. Rothman SM, Olney JW: Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299-302, 1987
47. Schröder ML, Muizelaar JP, Kuta AJ: Documented reversal of global ischemia immediately after removal of acute subdural hematoma. Report of two cases. J Neurosurg 80:324-327, 1994
48. Shapira Y, Yadid G, Cotev S, et al: Protective effect of MK801 in experimental brain injury. J Neurotrauma 7:131-139, 1990
49. Shimada N, Graf R, Rosner G, et al: Differences in ischemia-induced accumulation of amino acids in the cat cortex. Stroke 21:1445-1451, 1990
50. Shimada N, Graf R, Rosner G, et al: Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem 60:66-71, 1993
51. Shiraishi K, Sharp FR, Simon RP: Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study. J Cereb Blood Flow Metab 9: 765-773, 1989
52. Smith DH, Okiyama K, McIntosh T: Ketamine and magnesium attenuates memory loss after experimental brain injury. Soc Neurosci 17:167, 1991 (Abstract)
53. Smith DH, Okiyama K, Thomas M, et al: The effects of two novel NMDA antagonists on regional cation concentration and edema formation following experimental brain injury. J Cereb Blood Flow Metab 11 (Suppl 2):S300, 1991 (Abstract)
54. Smith DH, Okiyama K, Thomas M, et al: An NMDA receptor-associated glycine site antagonist attenuates memory loss after experimental brain injury. Soc Neurosci 2:779, 1990 (Abstract)
55. Smith DH, Thomas M, Soares H, et al: Differential effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists following experimental brain injury. J FASEB 4:400, 1990 (Abstract)
56. Takizawa S, Hogan M, Hakim AM: The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 11:786-793, 1991
57. Zauner A, Bullock R, Kuta AJ, et al: Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl 67:40-44, 1996
58. Zauner A, Doppenberg EMR, Woodward JJ, et al: Continuous monitoring of cerebral substrate delivery and clearance: initial experience in 24 patients with severe acute brain injuries. Neurosurgery 41:1082-1093, 1997